GI & Endoscopy

Cancer Treatment Centers of American in Tulsa, Okla., has added gastroenterologist Scott Hendrickson, DO, according to a Tulsa World report.

Fecal microbiome analysis has the potential to improve the accuracy of fecal occult blood testing for colorectal cancer, according to a Gastroenterology & Endoscopy News report. 

The Centers for Medicare and Medicaid Services has issued its final payment decision for Exact Sciences’ FDA-approved noninvasive stool DNA colorectal cancer screening test Cologuard.

Robert Holmes, MD, will sit on the newly formed medical advisory board of PMG Research, a network that provides clinical research services to pharmaceutical companies and CROs. 

Here are five gastroenterologists or GI groups who made the news within the past week.

Low-dose, enteric-coated aspirin tablets reduced colorectal tumor recurrence in an Asian population, according to a study published in Gut.

Surgeon Glenn Ihde, MD, has performed his 500th transoral incisionless fundoplication procedure at Forest Park Medical Center in Dallas.

Carnegie Hill Endoscopy in New York will hold an open house on Dec. 4 to showcase FUSE endoscopy technology.

Takeda Pharmaceuticals USA President Doug Cole is planning to leave his position at the end of the fiscal year in March or once a successor is named, according to a Crain's Chicago Business report.

Nov. 23 marked the beginning of National Gastroesophageal Reflux Disease Week. Jay N. Yepuri, MD, of Digestive Health Associates of Texas in Bedford, discusses advances in GERD treatment and how gastroenterologists can play an active role in improving patient awareness.